MedPath

To identify the presence of type 2 diabetes patients with elevated insulin clearance and clarify there clinical characteristics. determine factors that affect on blood insulin concentrations at steady state in hyperinsulinemic-euglycemic clamp test (insulin clearance).

Not Applicable
Conditions
ntreated type 2 diabetes mellitus
Registration Number
JPRN-UMIN000032014
Lead Sponsor
Jinnouchi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
101
Inclusion Criteria

Not provided

Exclusion Criteria

ketoacidosis, pregnancy, cancer, thyroid disease, adrenal tumor, renal failure, active infection, inflammatory disease, autoimmune disease, liver cirrhosis, Viral hepatitis, dementia, schizophrenia, and those who did not accept to have hyperinsulinemic-euglycemic clamp examination.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To identify patients with elevated insulin clearance assessed by hyperinsulinemic-euglycemic clamp test.
Secondary Outcome Measures
NameTimeMethod
To clarify there clinical characteristics.
© Copyright 2025. All Rights Reserved by MedPath